Cargando…

Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization

Matching material degradation with host remodeling, including endothelialization and muscular remodeling, is important to vascular regeneration. We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate. Furthermore, highl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Weiwei, Chen, Wanli, Wang, Yinggang, Zhang, Cun, Zhang, Xinchi, Zhang, Siqian, Wu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278867/
https://www.ncbi.nlm.nih.gov/pubmed/35857526
http://dx.doi.org/10.1126/sciadv.abn1958
_version_ 1784746277047631872
author Xiao, Weiwei
Chen, Wanli
Wang, Yinggang
Zhang, Cun
Zhang, Xinchi
Zhang, Siqian
Wu, Wei
author_facet Xiao, Weiwei
Chen, Wanli
Wang, Yinggang
Zhang, Cun
Zhang, Xinchi
Zhang, Siqian
Wu, Wei
author_sort Xiao, Weiwei
collection PubMed
description Matching material degradation with host remodeling, including endothelialization and muscular remodeling, is important to vascular regeneration. We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate. Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedentedly acquired carotid arterial regeneration in rabbit model. Through single-cell RNA sequencing analysis and cell tracing studies, a subset of endothelial progenitor cells, myeloid-derived CD93(+)/CD34(+) cells, was identified as the main contributor to final endothelium regeneration. To conclude, DTβ4-inspired porous 3DVGs present adjustable physical properties, superior anticoagulating, and re-endothelializing potentials, which leads to the regeneration of small-caliber artery, thus offering a promising tool for vessel replacement in clinical applications.
format Online
Article
Text
id pubmed-9278867
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-92788672022-07-29 Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization Xiao, Weiwei Chen, Wanli Wang, Yinggang Zhang, Cun Zhang, Xinchi Zhang, Siqian Wu, Wei Sci Adv Biomedicine and Life Sciences Matching material degradation with host remodeling, including endothelialization and muscular remodeling, is important to vascular regeneration. We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate. Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedentedly acquired carotid arterial regeneration in rabbit model. Through single-cell RNA sequencing analysis and cell tracing studies, a subset of endothelial progenitor cells, myeloid-derived CD93(+)/CD34(+) cells, was identified as the main contributor to final endothelium regeneration. To conclude, DTβ4-inspired porous 3DVGs present adjustable physical properties, superior anticoagulating, and re-endothelializing potentials, which leads to the regeneration of small-caliber artery, thus offering a promising tool for vessel replacement in clinical applications. American Association for the Advancement of Science 2022-07-13 /pmc/articles/PMC9278867/ /pubmed/35857526 http://dx.doi.org/10.1126/sciadv.abn1958 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Xiao, Weiwei
Chen, Wanli
Wang, Yinggang
Zhang, Cun
Zhang, Xinchi
Zhang, Siqian
Wu, Wei
Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization
title Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization
title_full Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization
title_fullStr Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization
title_full_unstemmed Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization
title_short Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93(+)/CD34(+) cells for endothelialization
title_sort recombinant dtβ4-inspired porous 3d vascular graft enhanced antithrombogenicity and recruited circulating cd93(+)/cd34(+) cells for endothelialization
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278867/
https://www.ncbi.nlm.nih.gov/pubmed/35857526
http://dx.doi.org/10.1126/sciadv.abn1958
work_keys_str_mv AT xiaoweiwei recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization
AT chenwanli recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization
AT wangyinggang recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization
AT zhangcun recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization
AT zhangxinchi recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization
AT zhangsiqian recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization
AT wuwei recombinantdtb4inspiredporous3dvasculargraftenhancedantithrombogenicityandrecruitedcirculatingcd93cd34cellsforendothelialization